SOLIGENIX, INC. 4
4 · SOLIGENIX, INC. · Filed Jan 8, 2014
Insider Transaction Report
Form 4
SOLIGENIX, INC.SNGX
Straube Richard
Sr VP & Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-01-06+100,000→ 100,000 totalExercise: $2.01From: 2014-01-06Exp: 2024-01-05→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock option vested immediately as to 25,000 shares and vests as to the remainder at a rate of 6,250 shares on each three (3) month anniversary of January 6, 2014.